language_icon
EN
HI

Jagsonpal Pharmaceuticals Share price

JAGSNPHARM

209.92

1.92 (-0.91%)
NSE
BSE
Last updated on 22 May, 2026 | 15:30 IST
Today's High

213.96

Today's Low

208.00

52 Week Low

155.00

52 Week High

301.65

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Jagsonpal Pharmaceuticals Chart

Jagsonpal Pharmaceuticals Share Key Metrics

Volume
1.99 L
Market Cap
1404.16 CR
LTQ@LTP
184@209.92
ATP
210.24
Var Margin
21.76 %
Circuit Range
169.48-254.2
Delivery %
41.33 %
Value
4.19 CR
ASM/GSM
No
Market Lot
1

Summary

Jagsonpal Pharmaceuticals share price is ₹209.92 as of 23 May, 2026. The stock Jagsonpal Pharmaceuticals intraday movement has stayed between ₹208.00 and ₹213.96, while on a 52-week basis,Jagsonpal Pharmaceuticals price 52 week high is ₹301.65 & its 52 week low is ₹155.00.
In terms of trading activity, Jagsonpal Pharmaceuticals has recorded a volume of 199462 shares, The Jagsonpal Pharmaceuticals has a market cap of ₹66890450 CR. The stock’s Average Traded Price (ATP) stands at ₹210.24, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 184 @ ₹209.92.
Jagsonpal Pharmaceuticals operates within a circuit range of ₹169.48 – ₹254.20, with a Value of ₹4.19 CR. The Delivery Percentage for the day is 41.33%. Additionally, Jagsonpal Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Jagsonpal Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

70.19

Sector P/B

3.46

Sec. Div. Yield

0.55

Jagsonpal Pharmaceuticals Resistance and Support

Pivot 207.62

Resistance

First Resistance

218.27

Second Resistance

224.7

Third Resistance

235.35

Support

First Support

201.19

Second Support

190.54

Third Support

184.11

Jagsonpal Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

67.89%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

2.44%

Domestic Institutional Investors

0.22%

Retail

29.45%

Others

0%

Total Promoters
MAR '26
67.89%

Jagsonpal Pharmaceuticals Corporate Actions

DateAgenda
2026-04-27Audited Results & Final Dividend
2026-03-12Buy Back of Shares
2026-01-21Quarterly Results
2025-11-03Quarterly Results
2025-07-26Quarterly Results
2025-05-06Audited Results & Final Dividend
2025-01-22Quarterly Results

Jagsonpal Pharmaceuticals News

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Jagsonpal Pharma's buyback offer period has commenced from May 08, 2026, until May 14, 2026. Shareholders are entitled to tender approximately 7.3% of their holdings.
May 07 2026 15:05:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Submission Of Letter Of Offer For Buy-Back Upto 16,00,000 Equity Shares

Jagsonpal Pharmaceuticals Ltd. has announced a buyback offer to acquire up to 1.6 million equity shares at Rs. 250 per share, totaling Rs. 40 crore. The buyback is via a tender offer route, with the record date set for May 04, 2026. Promoters have stated their intention not to participate, benefiting public shareholders.
May 06 2026 20:05:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Jagsonpal Pharma announced a buyback offer of up to 1.6 million equity shares, representing 2.39% of its total equity, for Rs. 250 per share. The total buyback size is Rs. 40 crore, offering a premium of approximately 40% over recent market prices. The record date for determining eligible shareholders is May 4, 2026, and promoters will not participate.
Apr 29 2026 17:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board approves Dividend

Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 21:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 16,00,000 Fully Paid-Up Equity Shares Of Face Value ?2/- Each At A Price Of ?250/- Per Share, For An Aggregate Amount Not Exceeding ?40 Crores

Jagsonpal Pharmaceuticals announced May 04, 2026 as the record date for its buyback. The company plans to acquire up to 16 lakh equity shares at ₹250/share, totaling ₹40 crores.
Apr 27 2026 20:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board to consider Dividend

Jagsonpal Pharmaceuticals board recommended a ₹4 per equity share dividend for FY26. This 200% payout is subject to shareholder approval at the upcoming AGM.
Apr 27 2026 19:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting

Jagsonpal Pharmaceuticals reported FY26 revenue of ₹287.23 crore, up 6.88% YoY, and a net profit of ₹43.08 crore, down 22.2% YoY. The board also recommended a final dividend of ₹4 per equity share for the year ended March 31, 2026.
Apr 27 2026 19:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00

Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Jagsonpal Pharmaceuticals shareholders approved buyback of up to 16 lakh equity shares at ₹250 each, totalling ₹40 crores, through postal ballot. The resolution passed with 99.99% votes in favour.
Apr 27 2026 07:04:00
Read More

About Jagsonpal Pharmaceuticals

NSE : 4410  
BSE : 507789  
ISIN : INE048B01035  

Jagsonpal Pharmaceuticals Management

NamePosition
Pratham RawalCompany Secretary & Compliance Officer
Harsha RaghavanChairperson
View More

Jagsonpal Pharmaceuticals FAQs

The Buying Price of Jagsonpal Pharmaceuticals share is 209.92 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 70.19 & 3.46 with sector averages, along with growth rates and financial metrics.

The Market Cap of Jagsonpal Pharmaceuticals is 1404.16 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 301.65 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Jagsonpal Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost